Difficulty: Medium
Average Score: 89%
Practice
A 50-year-male with pitting edema of the ankles develops gynecomastia and erectile dysfunction while being treated with which of the following agents?
Correct answer
C
Rationale
The correct answer is C) Spironolactone. Spironolactone is a potassium-sparing diuretic that can lead to gynecomastia and erectile dysfunction in males due to its anti-androgenic effects. It works by blocking the effects of aldosterone, leading to potassium retention and increased levels of estrogen, causing these side effects.
Option A) Hydrochlorothiazide is a thiazide diuretic that can cause electrolyte imbalances but is not typically associated with gynecomastia or erectile dysfunction.
Option B) Metolazone is a thiazide-like diuretic that can also lead to electrolyte imbalances but is not known to cause gynecomastia or erectile dysfunction.
Option D) Triamterene is a potassium-sparing diuretic, like spironolactone, but it does not have anti-androgenic effects, so it is not associated with gynecomastia or erectile dysfunction.
In an educational context, understanding the side effects of medications used in the treatment of conditions involving the female reproductive system, such as polycystic ovary syndrome or hirsutism, is crucial for healthcare professionals to provide safe and effective care to their patients. It is important to be aware of the potential adverse effects of medications to monitor and manage them appropriately.
Option A) Hydrochlorothiazide is a thiazide diuretic that can cause electrolyte imbalances but is not typically associated with gynecomastia or erectile dysfunction.
Option B) Metolazone is a thiazide-like diuretic that can also lead to electrolyte imbalances but is not known to cause gynecomastia or erectile dysfunction.
Option D) Triamterene is a potassium-sparing diuretic, like spironolactone, but it does not have anti-androgenic effects, so it is not associated with gynecomastia or erectile dysfunction.
In an educational context, understanding the side effects of medications used in the treatment of conditions involving the female reproductive system, such as polycystic ovary syndrome or hirsutism, is crucial for healthcare professionals to provide safe and effective care to their patients. It is important to be aware of the potential adverse effects of medications to monitor and manage them appropriately.